A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system

Peter E. Manley*, Tanya Trippett, Amy A. Smith, Margaret E. Macy, Sarah E.S. Leary, Jessica Boklan, Kenneth J. Cohen, Stewart Goldman, Lindsay B. Kilburn, Girish Dhall, Jeanne Devin, Cynthia E. Herzog, Sonia Partap, Floris Fauchet, Emmy Badreddine, John P. Bernard, Susan N. Chi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system'. Together they form a unique fingerprint.

Medicine & Life Sciences